US EditionLooking Into the Future and at Unmet Needs in EGFRm NSCLC
Summary by onclive.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Looking Into the Future and at Unmet Needs in EGFRm NSCLC
Panelists discuss how medical professionals identify key unmet needs in EGFR-mutated non–small cell lung cancer (NSCLC) treatment, particularly in overcoming resistance. Challenges include addressing acquired resistance to targeted therapies, enhancing central nervous system penetration, managing toxicity, and developing novel agents or combinations to improve long-term outcomes.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage